Study finds benefits listed in larger text than risks in mags

Share this article:
A study of oncology drug ads in the magazines CURE, Coping With Cancer and MAMM found benefits presented more prominently and in larger text than risks. The study, presented to the American Society of Clinical Oncology's annual meeting, found that while benefits usually placed in the top third of the ad space, risks were often presented in smaller type and relegated to the lower half of the page.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.